NorthStar Asset Management (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,850
Closed -$218K 145
2024
Q4
$218K Sell
3,850
-748
-16% -$41.8K 0.05% 139
2024
Q3
$238K Sell
4,598
-1,100
-19% -$51.6K 0.05% 137
2024
Q2
$237K Sell
5,698
-400
-7% -$17.9K 0.06% 136
2024
Q1
$331K Buy
6,098
+600
+11% +$30.6K 0.08% 124
2023
Q4
$282K Buy
5,498
+350
+7% +$18.4K 0.07% 130
2023
Q3
$299K Buy
5,148
+800
+18% +$49K 0.09% 116
2023
Q2
$278K Buy
4,348
+479
+12% +$32.1K 0.08% 122
2023
Q1
$268K Buy
3,869
+769
+25% +$54.2K 0.08% 121
2022
Q4
$223K Hold
3,100
0.07% 132
2022
Q3
$220K Hold
3,100
0.07% 128
2022
Q2
$239K Sell
3,100
-600
-16% -$45.7K 0.07% 124
2022
Q1
$270K Hold
3,700
0.07% 129
2021
Q4
$231K Hold
3,700
0.05% 139
2021
Q3
$219K Hold
3,700
0.06% 139
2021
Q2
$247K Buy
3,700
+100
+3% +$6.52K 0.06% 132
2021
Q1
$227K Hold
3,600
0.06% 127
2020
Q4
$223K Sell
3,600
-50
-1% -$3.07K 0.06% 128
2020
Q3
$220K Hold
3,650
0.07% 120
2020
Q2
$215K Hold
3,650
0.08% 118
2020
Q1
$203K Buy
3,650
+150
+4% +$9.17K 0.09% 108
2019
Q4
$225K Buy
+3,500
New +$200K 0.08% 115
2018
Q4
Sell
-6,451
Closed -$400K 109
2018
Q3
$400K Buy
6,451
+21
+0.3% +$1.25K 0.16% 89
2018
Q2
$356K Sell
6,430
-4,220
-40% -$228K 0.15% 88
2018
Q1
$673K Buy
10,650
+100
+0.9% +$6.43K 0.28% 72
2017
Q4
$647K Hold
10,550
0.27% 72
2017
Q3
$672K Sell
10,550
-75
-0.7% -$4.38K 0.29% 73
2017
Q2
$592K Sell
10,625
-585
-5% -$31.8K 0.27% 79
2017
Q1
$610K Sell
11,210
-1,500
-12% -$82.3K 0.27% 75
2016
Q4
$743K Sell
12,710
-295
-2% -$16.1K 0.34% 68
2016
Q3
$701K Sell
13,005
-385
-3% -$24.7K 0.29% 73
2016
Q2
$985K Sell
13,390
-60
-0.4% -$4.24K 0.41% 54
2016
Q1
$859K Buy
13,450
+475
+4% +$30K 0.37% 62
2015
Q4
$892K Buy
12,975
+1,000
+8% +$66.1K 0.38% 59
2015
Q3
$709K Buy
11,975
+2,200
+23% +$140K 0.32% 65
2015
Q2
$650K Hold
9,775
0.27% 68
2015
Q1
$630K Hold
9,775
0.27% 71
2014
Q4
$577K Sell
9,775
-2,300
-19% -$130K 0.25% 70
2014
Q3
$618K Buy
12,075
+530
+5% +$26.5K 0.27% 69
2014
Q2
$560K Buy
+11,545
New +$569K 0.24% 70

Other funds holding BMY

NorthStar Asset Management (Pennsylvania)'s BMY Position: Q1 2025 in Review

NorthStar Asset Management (Pennsylvania) sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 3,850 shares — an estimated $218K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in BMY in Q2 2014 and held it in 39 quarters. The position peaked at $985K in Q2 2016. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • NorthStar Asset Management (Pennsylvania) reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • NorthStar Asset Management (Pennsylvania) sold 3,850 Bristol-Myers Squibb shares in Q1 2025, an estimated $218K.
  • NorthStar Asset Management (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 39 quarters.
  • NorthStar Asset Management (Pennsylvania)'s Bristol-Myers Squibb position peaked at $985K in Q2 2016.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2025, filed 29 Apr 2025.